Yadda ake amfani da Listat?

Kadan za su iya yin fahariya da adadi mai kyau da kuma ɗimbinsu. Wasu an ba su nauyin kiba ta Iya Nature, yayin da wasu suka sami karin fam a duk rayuwarsu. Kuma dalilai na wannan na iya zama daban, alal misali, magani tare da kwayoyi na hormonal. Mafi yawan lokuta, mutane sukan cire fatarar ajiya mai yawa a cikin hanyar folds a kowane hanya mai yiwuwa. A cikin waɗannan halayen lokacin da kayan abinci da aikin jiki kusan ba sa adanawa, waɗanda ke neman rasa nauyi zuwa ƙarshen, a ra'ayinsu, hanya - magunguna kan magunguna don asarar nauyi. A cikin wannan labarin, mun koyi kadan game da magani kamar Listata.

“Listata” - menene wannan magani?

Ta hanyar aikin aiwatarwa, wannan kayan aikin shine mai toshe mai. Don haka, kitse baya jikin mutum, kuma a haka ana rage adadin kuzari abinci.

Magunguna don ragewa da kuma kawar da karin fam na "Listat" sake dubawa na likitoci da marasa lafiya sun haɗu. Amma sun yarda da ra'ayi daya cewa ya zama dole a hada shan magungunan tare da rage yawan hypocaloric. Yana da kyau a kara yawan motsa jiki yayin wannan lokacin. Sannan sakamakon allunan zai zama sananne.

A lokacin jiyya, wajibi ne don rage yawan kitse. Wannan zai rage aukuwar tasirin sakamako. Ana amfani da miyagun ƙwayoyi a cikin nau'ikan allunan madaidaiciya masu launin shuɗi kuma suna da siffar m. Kuna iya siyan ta a cikin kantin magunguna na musamman. Kada ku sayi kaya a cikin wurin da ba a tabbatar da su ba sannan ku yi hattara da fakes!

Me aka yi maganin?

Abun da ke cikin miyagun ƙwayoyi ya haɗa da babban sashi mai aiki - orlistat. Abubuwan, shiga cikin gastrointestinal fili, yana lalata enzymes wanda ke rushewar mai. Fatan jikin ba zai iya ɗaukar mai ba. Daga wannan yana zuwa wancan ɓangaren mai a madawwamiyar wucewa zuwa cikin hanjin, ba tare da shiga wurare dabam dabam ba. Kowane kwamfutar hannu yana dauke da 60-120 MG na orlistat. Wato, kusan kashi ɗaya cikin huɗu na duk fats ɗin da ke shiga jiki ana katange shi lokacin shan 1 kwamfutar hannu irin wannan magani kamar "Listata" don asarar nauyi. Nazarin haƙuri game da wannan magani yana bayyana sakamako masu illa, waɗanda za mu gaya muku game da shi.

Abu na biyu mai mahimmanci na miyagun ƙwayoyi shine acacia gum. Ba ya barin kitse ya taru a cikin babban clots, wato, yana gauraya shi da abubuwan da ake dasu daban-daban. Acacia gum bai shafi nauyin jikin mutum ta kowace hanya, amma yana ba shi damar sassauƙa sakamakon tasirin magani. Wannan shine, haƙurin maganin "Listata" (sake dubawar wasu marasa lafiya sun tabbatar da wannan gaskiyar) yana inganta. Sakamakon abubuwa masu aiki, Listata yana da fa'ida a kan kwayoyi masu kama da wannan don asarar nauyi.

Alamu don amfani

Shawarwarin likita wanda likita ya ba da magani kamar su Allata Allunan (ƙaddamarwar haƙuri sun tabbatar da wannan bayanin) sune:

A bayyane yake cewa daga allunan kadai za'a sami fa'idodi kaɗan. Shan magunguna dole ne a haɗe shi da abinci.

Sashi da Gudanarwa

Ana amfani da miyagun ƙwayoyi a cikin allunan magunguna daban-daban - 120 mg da 60 mg (mini), guda 30-60 kowane fakiti. Ana ɗaukar "Listata" sau 3 a rana don MG 120, tabbatar da cewa za ku ci ko ba a wuce sa'a ɗaya ba bayan cin abinci, in ba haka ba kayan aikin ba za su yi aiki ba. Ainihin magani shine watanni 6.

Idan abincin ya tsallake ko abincin bai ƙunshi kitse ba, ba za a yi amfani da maganin Listata (120 mg) ba, ba ayi amfani da sake duba su ba a ƙasa. An rubuta wannan a cikin umarnin don amfanin wannan magani. Theara kashi a sama wannan baya ƙaruwa da warkewa.

Side effects

Sakamakon sakamako na iya faruwa bayan ɗaukar magani "Listata". Nazarin asarar nauyi ya ce da gaske duk alamu marasa dadi suna faruwa ne daga hanji.

Abubuwan da suka biyo baya sune halayen magungunan Listata slimming:

1. Oolara yawan stool.
2. Cire mai mai daga dubura.
3. Karya yakeyi don cin nasara.
4. Rashin daidaituwa.
5. Bleedingarancin zub da jini daga dubura.

Bugu da kari, idan aka yi amfani da kwayoyin hana daukar abinci na “Listat” tsawon watanni (dubawar marasa lafiya sun bayyana wannan gaskiyar), to sauran alamun gefen suna bayyana, kamar:

1. Allergic fata fitsari.
2. Ciwon kai.
3. Damuwar bacci.
4. Samuwar gallstones.
5. Rashin lafiyar hanta.
6. Dizziness

Fitar da wasu kwayoyi

Tabbatar yin la'akari da gaskiyar cewa "Listata" na iya hulɗa tare da wasu kwayoyi. Abubuwan da ke aiki a cikin ƙwayar (orlistat) suna haifar da lalata lalata enzymes mai-mai narkewa. Tare da kitsen, jikin mutum baya ɗaukar babban adadin bitamin mai mahimmanci. Bugu da kari, mucosa na hanji an rufe shi da kitse mara kyau, kuma, gwargwadon haka, yanayinsa bai sami sauki daga wannan ba. Kodayake a zahiri, ba'a lura da hypovitaminosis koda bayan tsawanta na amfani da miyagun ƙwayoyi "Listata". Binciken, umarnin don amfani yana ba da shawarar cewa yin amfani da kwayoyi don asarar nauyi yana rage tasirin maganin hana haihuwa. Wannan na iya haifar da zubar da ciki wanda ba a so. Orlistat kuma yana rage tasirin magungunan antiepileptic. Don guje wa ma'amala mara kyau tsakanin magunguna, wajibi ne a dauki “listat” dabam da sauran magunguna.

Nazarin asarar nauyi

Yin hukunci da bita da yawa, "Listata" ba magani bane mai dacewa ga mutanen da ke jagorantar rayuwa mai aiki. Tun da tafiye-tafiye na yau da kullun zuwa bayan gida ba zai iya ba da gudummawa ga aiki mai amfani ba. A bayyane yake cewa sakamako masu illa da ke haifar da orlistat, ta kowace hanya suna tsoma baki ga hanyar rayuwa. Amma wannan yana da halayensa masu inganci. Bayan haka, lokacin da mutum ya ƙi cin abinci mai ɗaci, to kuwa asirinsa yakan zama daidai. Wato, mutum yana jin tsoron sakamako masu illa, saboda haka, shi kansa ya rage yawan abinci mai mai yawa. Kuma wannan yana ba shi damar haɓaka halayen abinci masu ƙoshin lafiya wanda zai taimaka nan gaba.

Wasu mata sun fusata cewa lokacin da suka shan magungunan Listata (akwai sake dubawa da yawa game da wannan matsalar), dole ne su sa pads. Cire mai mai daga dubura sau da yawa yakan faru, wanda yake da daɗi da rashin walwala. Marasa lafiya suna koka game da zafin ciki da ƙaruwar rashin lafiya. Mutane da yawa ba su yarda da miyagun ƙwayoyi "Listata" da kayan aikinta ba.

Duk da duk alamun rashin jin daɗin da ke haifar da shan maganin, tasirinsa yana da tasiri sosai.

Contraindications

Idan kuna da sha'awar zama mai dantse, zaku iya amfani da miyagun ƙwayoyi "Listata" don asarar nauyi. Yin bita da masaniyar, dangi da abokai kada su kasance hujja madaidaiciya ta dace da wannan maganin. Tattaunawa tare da ƙwararren ƙwararriyar ya zama dole, saboda a cikin wasu halayen an hana maganin. Ba'a amfani da wannan magani a cikin waɗannan abubuwan:

1. Hypersensitivity da rashin haƙuri zuwa ga aka gyara.
2. Cholestasis.
3. Yara da matasa, wato har zuwa shekaru 18.
4. Rashin narkewar abinci na yau da kullun, rikicewar jigilar kaya da ɗaukar abubuwan gina jiki a cikin ƙananan hanji, da dai sauransu.

Yin amfani da miyagun ƙwayoyi yayin daukar ciki da lactation

Shin akwai ingantattun bayanan asibiti akan amincin miyagun ƙwayoyi Listata? Binciken mata masu juna biyu ya nuna cewa masu halartar asibitin sun hana su amfani da wannan magani. Babu bayanan aminci, don haka likita ya yi abin da ya dace. Bayan duk wannan, ba a san yadda magunguna don rage nauyi “Listat” zai shafi mahaifiyar da tayin ba kuma abin da hakan na iya barazanar gaba. Hakanan ba a tabbatar dashi ko orlistat ya shiga cikin madara ba. Don haka, amfani da kwayoyin hana daukar ciki lokacin shayarwa ba a so.

Umarni na musamman don amfani

Hanyoyin mahimmancin sarrafa nauyi shine abinci mai dacewa da aiki na jiki. Wajibi ne a bi waɗannan ka'idodin kafin ɗaukar shirin “Listata”. Nazarin masu haƙuri sun nuna cewa bin man kalori mai ƙarancin abinci tare da mafi ƙarancin mai mai ('ya'yan itace, kayan lambu), zaku iya rage haɗarin sakamako masu illa daga ƙwayar gastrointestinal. Kodayake mutane da yawa sun dogara da miyagun ƙwayoyi gaba daya, yayin da suke mantawa game da abinci mai kyau da wasanni.

Marasa lafiya tare da matsalolin koda suna buƙatar shawarar likita game da amfani da magani na Listata, saboda akwai haɗarin wasu cututtuka.

Tare da asarar nauyi daga amfani da magungunan rage cin abinci a cikin marasa lafiya da ciwon sukari, metabolism metabolism na iya daidaita al'ada. A wannan yanayin, shawarwarin likitocin halartar ma sun zama dole. Lokacin kawar da karin fam a cikin mutum, hawan jini da matakan cholesterol na jini na iya raguwa. Wannan dole ne a la'akari da likitan lokacin da yake rubuta magunguna.

Idan waɗannan bayyanar cututtuka sun bayyana bayan shan allunan Listat, ya kamata ku hanzarta ganin likita kuma kuyi shawara game da shan maganin, saboda yana iya fara aiwatar da aikin hanta mai rauni:

1. Gajiya.
2. Rashin ƙarfi.
3. Dark fitsari.
4. Zazzaɓi.

Marasa lafiya waɗanda suka ɗauki ƙwayar "Listata" suna barin bita daban-daban: tsaka tsaki, tabbatacce kuma mara kyau. Kamar yadda kuka sani, mutane nawa, ra'ayoyi da yawa. Dukkanta ya dogara ne da yanayin lafiyar ɗan adam da yanayin halayen mutum. Ba'a ba da shawarar yin allurar da kanka kowane magani ba, gami da magungunan abinci. Tabbas, kuna buƙatar sha'awar sake dubawa game da maganin, amma yakamata ku nemi likita don shawara akan amfani da wannan ko maganin.

Yadda ake amfani: sashi da hanya na jiyya

Ana ɗaukar allunan a baki da ruwa.

Kula da marasa lafiya masu kiba tare da BMI na aƙalla 30 kg / m2 ko kuma masu kiba masu yawa tare da BMI na aƙalla 28 kg / m2, gami da alaƙa da abubuwan haɗarin kiba, haɗe tare da rage yawan kalori

Manya da yara sama da shekara 12: maganin da aka bada shawarar magani shine kwamfutar hannu 1 (120 MG) tare da kowane babban abinci (tare da abinci ko kuma ba a wuce sa'a 1 ba bayan cin abinci).

A haɗuwa tare da magungunan hypoglycemic (metformin, abubuwan da ake samowa na sulfonylurea da / ko insulin) da / ko rage yawan hypocaloric na abinci a cikin marasa lafiya da ke fama da nau'in ciwon sukari na 2 na masu fama da kiba.

Manya: maganin da aka ba da shawarar maganin shine kwamfutar hannu 1 (120 MG) tare da kowane babban abinci (tare da abinci ko kuma bai wuce 1 hour ba bayan cin abinci).

Idan kun tsallake cin abinci ko idan abincin bai ƙunshi mai ba, zaku iya tsallake abincin.

Shan miyagun ƙwayoyi ya kamata a haɗe shi tare da daidaitaccen, yawan hypocaloric rage cin abinci wanda ya ƙunshi adadin kuzari fiye da 30% a cikin mai. Abincin yau da kullun na kitse, carbohydrates da sunadarai dole ne a rarraba tsakanin manyan abinci 3.

Theara yawan kashi sama da shawarar (120 mg sau 3 a rana) ba ya haifar da ƙaruwa a cikin tasirin warkewarta.

Ba a bincika tasiri da amincin miyagun ƙwayoyi a cikin marasa lafiya da ke fama da hanta da / ko aikin koda, da a cikin tsofaffi marasa lafiya da yara waɗanda shekarunsu ba su 12 ba.

Aikin magunguna

Orlistat ƙaƙƙarfan ƙarfi ne, takamaiman kuma mai canzawa mai hana ƙwayar ciki tare da sakamako mai dorewa. Its da warkewa sakamako ne da za'ayi a cikin lumen na ciki da ƙananan hanji da kuma kunshi a cikin samuwar wani covalent bond tare da aiki serine yankin na na ciki da kuma pancreatic lipases. A wannan yanayin, enzyme wanda aka kunna ya rasa ikonsa na rushe kitsen abinci a cikin nau'in triglycerides zuwa cikin mayukan kitse mai narkewa da monoglycerides. Tunda ba a shanyewar triglycerides marasa amfani, sakamakon raguwar yawan adadin kuzari yana haifar da raguwar nauyin jiki. Saboda haka, warkewa sakamako na miyagun ƙwayoyi ana aiwatar da shi ba tare da ɗauka cikin jini ba.

Tasirin maganin yana farawa awanni 24-48 bayan gudanarwa. An dawo da ayyukan ƙwayar gastrointestinal kamar 48-72 sa'o'i bayan dakatar da jiyya.

A cikin marasa lafiya suna shan orlistat, akwai asara mai yawa a cikin nauyin jiki idan aka kwatanta da marasa lafiya game da ilimin abinci. Rashin nauyi yana farawa a tsakanin makonni 2 na farko bayan farawar magani kuma yana kasancewa daga watanni 6 zuwa 12, har ma a cikin marasa lafiya da mummunar amsa game da ilimin abinci. A cikin shekaru 2, an sami babban ci gaba na ƙididdiga a cikin bayanan abubuwan haɗari na rayuwa wanda ya danganta da kiba. Bugu da kari, idan aka kwatanta da placebo, akwai raguwa sosai a yawan kitse a jiki. Orlistat yana da tasiri don hana maimaita yawan amfani. An sake maimaita girman nauyin, ba fiye da 25% na batattu ba, ana lura da shi a cikin kusan rabin marasa lafiya, kuma a cikin rabin waɗannan marasa lafiya, ba a lura da maimaita yawan nauyin ba, ko ma an sami ƙarin raguwa.

Marasa lafiya da nauyin jiki ya wuce kima ko kiba da nau'in ciwon suga guda 2 mellitus shan orlistat na tsawon watanni 6 zuwa shekara 1 suna da asara mai yawa a jikin mutum idan aka kwatanta da marasa lafiya da ke karɓar abinci shi kaɗai. Rage nauyi yana faruwa ne sakamakon raguwar yawan kitse a jiki. Lokacin gudanar da aikin maganin orlistat, ana lura da ƙididdigar ƙwaƙwalwa da babban asibiti a cikin kulawar glycemic. Bugu da ƙari, yayin maganin orlistat, ana rage raguwa a cikin adadin wakilai na hypoglycemic, taro insulin, haka nan an lura da raguwar juriya na insulin.

Tare da yin amfani da miyagun ƙwayoyi na tsawon shekaru 4, haɗarin haɓaka nau'in ciwon sukari na 2 wanda ya ragu sosai (kusan 37% idan aka kwatanta da placebo). Matsakaicin raguwar haɗari ya kasance mafi mahimmanci a cikin marasa lafiya tare da raunin glucose na farko (kusan 45%).

Ana kiyaye nauyin jikin mutum a wani sabon matakin a duk tsawon lokacin amfani da miyagun ƙwayoyi.

Lokacin amfani da miyagun ƙwayoyi na shekara 1, ƙwararrun masu cutar ƙwaƙwalwar ƙwayar cuta suna da raguwa a cikin ƙirar jiki (BMI), raguwa a cikin mai mai yawa, har da kugu da kwatangwalo idan aka kwatanta da ƙungiyar placebo. Bugu da ƙari, an sami raguwa sosai a cikin karfin jini na jini (BP) idan aka kwatanta da ƙungiyar placebo.

Tsarin ilimin rayuwa (ICD-10)

Pharmacodynamics

Orlistat ƙaƙƙarfan ƙarfi ne, takamaiman kuma mai sakewa mai hana ƙwayoyin ciki tare da sakamako mai dorewa.Its da warkewa sakamako ne da za'ayi a cikin lumen na ciki da ƙananan hanji da kuma kunshi a cikin samuwar wani covalent bond tare da aiki serine yankin na na ciki da kuma pancreatic lipases. A wannan yanayin, enzyme wanda aka kunna ya rasa ikonsa na rushe kitsen abinci a cikin nau'in triglycerides zuwa cikin mayukan kitse mai narkewa da monoglycerides. Tunda ba a shanyewar triglycerides marasa amfani, sakamakon raguwar yawan adadin kuzari yana haifar da raguwar nauyin jiki. Saboda haka, warkewa sakamako na miyagun ƙwayoyi ana aiwatar da shi ba tare da ɗauka cikin jini ba.

Yin hukunci da sakamakon kitsen mai a cikin feces, sakamakon orlistat yana farawa awanni 24 da 48 bayan fitowar. Bayan sokewar orlistat, mai mai a cikin feces bayan 48-722 yawanci yakan dawo zuwa matakin da ya faru kafin farkon farfaɗo.

Marasa lafiya da ke shan orlistat suna nuna asarar nauyi mafi girma idan aka kwatanta da marasa lafiya kan hanyoyin rage cin abinci. Rashin nauyi yana farawa a tsakanin makonni 2 na farko bayan farawar magani kuma yana kasancewa daga watanni 6 zuwa 12, har ma a cikin marasa lafiya da mummunar amsa game da ilimin abinci. A cikin shekaru 2, an sami babban ci gaba na ƙididdiga a cikin bayanan abubuwan haɗari na rayuwa wanda ya danganta da kiba. Bugu da kari, idan aka kwatanta da placebo, akwai raguwa sosai a yawan kitse a jiki. Orlistat yana da tasiri don hana maimaita yawan amfani. An sake maimaita girman nauyin, ba fiye da 25% na batattu ba, ana lura da shi a cikin kusan rabin marasa lafiya, kuma a cikin rabin rabin marasa lafiya, ba a lura da maimaita yawan nauyin ba, ko ma an sami ƙarin raguwa.

Marasa lafiya tare da kiba ko kiba da nau'in ciwon sukari na 2 wanda suke shan orlistat na watanni 6-12 suna da asarar nauyi mai yawa idan aka kwatanta su da marasa lafiya da suke karɓar abinci shi kaɗai. Rage nauyi yana faruwa ne sakamakon raguwar yawan kitse a jiki. Lokacin gudanar da aikin maganin orlistat, ana lura da ƙididdigar ƙwaƙwalwa da babban asibiti a cikin kulawar glycemic. Bugu da ƙari, yayin maganin orlistat, ana rage raguwa a cikin adadin wakilai na hypoglycemic, taro insulin, haka nan an lura da raguwar juriya na insulin.

Tare da yin amfani da orlistat na tsawon shekaru 4, haɗarin haɓaka nau'in ciwon sukari na 2 wanda ke da raguwa sosai (kusan 37% idan aka kwatanta da placebo). Matsakaicin raguwar haɗari ya kasance mafi mahimmanci a cikin marasa lafiya tare da raunin glucose na farko (kusan 45%).

Ana kiyaye nauyin jikin mutum a wani sabon matakin a duk tsawon lokacin amfani da miyagun ƙwayoyi.

Lokacin amfani da orlistat na shekara 1, ƙwararrun balagaggu suna da raguwa a cikin ƙirar jiki (BMI), mai mai yawa, har da kugu da kwatangwalo idan aka kwatanta da ƙungiyar placebo. Hakanan, marasa lafiya da ke karɓar maganin orlistat sun nuna raguwa mai yawa a cikin DBP idan aka kwatanta da ƙungiyar placebo.

Pharmacokinetics

Damuwa. A cikin masu sa kai tare da nauyin jiki na al'ada da kiba, ƙimar ƙaƙƙarfan ƙwayar orlistat ba ta da yawa. Bayan kashi ɗaya na ƙwayar 360 na mg, orlistat wanda ba a canza shi ba cikin plasma jini ba'a ƙaddara shi ba, wanda ke nufin cewa haɗuwarsa yana ƙasa da ƙayyadaddun quantification (ƙasa da 5 ng / ml).

Gabaɗaya, bayan ɗaukar allurai na warkewa, an gano orlistat a cikin jini na jini kawai a lokuta mafi wuya, yayin da yake haɗuwa sosai ƙananan (ƙasa da 10 ng / ml ko 0.02 μmol). Babu alamun tarawa, wanda ke tabbatar da cewa shan orlistat ƙanƙane.

Rarraba. V_d ba za a iya tantancewa ba, tunda Orlistat yana da matukar shan wahala. A cikin vitro orlistat sama da 99% suna ɗaure su don ƙwayoyin plasma (galibi tare da lipoproteins da albumin). A cikin ƙarancin adadi, orlistat na iya shiga cikin sel jini.

Tsarin rayuwa. Metabolism na Orlistat yana faruwa ne musamman a bango na hanji. A cikin marasa lafiya tare da kiba, kusan 42% na ƙaramar juzu'in na orlistat, wanda ke shan ƙwaƙwalwar tsarin, an lasafta shi ta hanyar manyan metabolites guda biyu - M1 (ƙwaƙwalwar lactone huɗu masu ƙarfi hydrolyzed) da M3 (M1 tare da ɓoyayyiyar N-formylleucine saura).

Molecules M1 da M3 suna da zobe β-lactone mai buɗewa kuma yana da rauni sosai a hana lipase (mai rauni fiye da orlistat, sau 1000 da 2500, bi da bi). Bayar da irin wannan ƙananan inhibitory aiki da ƙananan ƙwayar plasma (a kan matsakaita 26 da 108 ng / ml, bi da bi) bayan shan allurai warkewa, waɗannan metabolites suna ɗaukar magunguna marasa aiki.

Kiwo. A cikin mutane masu al'ada da kuma nauyin kiba, babban hanyar shakatawa shine excretion na orlistat wanda ba zai iya ɗaukar ciki ba ta cikin hanji. Kimanin kashi 97% na kashin da aka yarda an fesa shi ta cikin hanji, tare da kashi 83% a cikin yanayin maye. Jimlar warewar dukkan abubuwan masarafi da ke hade da orlistat bai wuce 2% na maganin da aka dauka ba. Lokaci don kammala cire orlistat daga jiki (ta hanjin ciki da kodan) shine kwanaki 3-5. Matsakaicin jerin abubuwan shakatawa na Orlistat a cikin masu sa kai tare da al'ada da kiba sun kasance iri ɗaya. Dukansu orlistat da metabolites M1 da M3 na iya zama daɗaɗa tare da bile.

Groupsungiyoyin haƙuri na musamman

Yara. Haɗarin ƙwaƙwalwa na orlistat da metabolites (M1 da M3) a cikin jini na jini a cikin yara ba su bambanta da waɗanda suke cikin manya ba idan aka gwada guda allurai na orlistat. Fitowar abinci mai na yau da kullun tare da feces shine kashi 27% na abincin da ake ci yayin shanyewar motsa jiki.

Alamun magunguna Listata

magani na dogon lokaci na marasa lafiya masu kiba tare da BMI na akalla 30 kg / m 2 ko marasa lafiya masu kiba da BMI na akalla 28 kg / m 2, incl. yana da abubuwan haɗari da ke haɗuwa da kiba, a haɗe tare da tsarin abinci na hypocaloric na matsakaici,

a hade tare da magunguna na hypoglycemic (metformin, abubuwan da ake samowa na sulfonylurea da / ko insulin) da / ko abinci mai ƙoshin lafiya na matsakaici a cikin marasa lafiya da ke fama da nau'in ciwon sukari na 2 na masu ƙiba ko masu kiba.

Haihuwa da lactation

A cikin nazarin cututtukan cututtukan dabbobi a cikin dabbobi, ba a lura da cutar teratogenic da tayi ba. Idan babu tasirin teratogenic a cikin dabbobi, ba a tsammanin irin wannan sakamako a cikin mutane. Tunda babu wani bayanan asibiti game da amfani da Orlistat yayin daukar ciki, yin amfani da Listat a cikin mata masu juna biyu.

Saboda gaskiyar cewa babu wani bayani game da sakin orlistat tare da madara, amfani da Listat lokacin shayarwa yana kare.

Side effects

Bayanin gwaji na asibiti

Sakamakon sakamako na miyagun ƙwayoyi an tsara su bisa ga tsarin kowane tsarin dangane da yawan abubuwan da ke faruwa, ta amfani da rarrabuwa mai zuwa: sau da yawa - fiye da 1/10, sau da yawa fiye da 1/100, ƙasa da 1/10, sau da yawa - fiye da 1/1000, ƙasa da 1 / 100, da wuya - fiye da 1/10000, ƙasa da 1/1000, ba wuya, ciki har da saƙonni guda - ƙasa da 1/10000.

Abubuwan da ba su dace ba tare da amfani da orlistat ya faru ne musamman daga maƙarƙashiyar ciki kuma sun kasance saboda aikin magunguna na Orlistat, wanda ke hana ɗaukar ƙashin abinci. Mafi yawan lokuta, abubuwan mamaki kamar zubar mai daga dubura, gas tare da wani adadin fitarwa, mahimmancin hanzari don lalacewa, steatorrhea, ƙara yawan motsin hanji, kumburin kwance, ƙoshin wuta, zafin ciki ko rashin jin daɗi. Yawan su yana ƙaruwa da haɓakar mai a cikin abinci. Yakamata a sanar da marassa lafiya game da yiwuwar kamuwa da cuta daga hanji sannan a koyar da yadda ake kawar dasu ta hanyar bin abinci, musamman dangane da yawan kitse da yake ciki. Yin amfani da karancin abinci mai kitse yana rage yiwuwar sakamako masu illa daga hanji don haka yana taimaka wa marassa lafiya don sarrafawa da daidaita yawan mai. A matsayinka na mai mulkin, waɗannan halayen masu haɗari suna da laushi da sassauci Suna faruwa a farkon matakan kulawa (a cikin watanni 3 na farko), kuma yawancin marasa lafiya basu da fiye da ɗayan ɗayan irin waɗannan halayen.

Daga cikin jijiyoyin mahaifa: sau da yawa - “m” bargo, zafi ko rashin jin daɗi a cikin dubura, fecal rashin daidaituwa, bloating, hakori cutar, cuku cuta.

Wasu m halayen: sau da yawa sau da yawa - ciwon kai, babba na numfashi fili kamuwa da cuta, mura, sau da yawa m na numfashi fili kamuwa da cuta, urinary fili kamuwa da cuta, dysmenorrhea, tashin hankali, rauni.

A cikin marasa lafiya da ke da nau'in ciwon sukari na 2 na sukari, yanayin da muguwar haɗari sun kasance daidai da waɗanda ke cikin mutane ba tare da ciwon sukari ba tare da kiba da kiba. Onlyarin ƙarin sakamako na sakamako a cikin marasa lafiya da ke da nau'in ciwon sukari na 2 na sukari shine yanayin rashin ƙarfi wanda ya faru tare da adadin fiye da 2% kuma abin da ya faru aƙalla 1% idan aka kwatanta da placebo (wanda zai iya haifar da ingantaccen diyya don metabolism na metabolism), kuma sau da yawa yana haɓaka.

A cikin nazarin asibiti na 4-shekara, bayanan lafiyar gaba ɗaya bai bambanta da wannan da aka samu a cikin karatun shekaru 1 da 2 ba. A lokaci guda, yawan tasirin abubuwan da ke faruwa daga muguwar mahaifa ya ragu kowace shekara a cikin shekaru 4 na shan miyagun ƙwayoyi.

An bayyana abubuwan da ke tattare da halayen rashin lafiyan, babban alamun bayyanar cututtukan da suka kasance fatar fata, itching, urticaria, angioedema, bronchospasm da anaphylaxis.

Yawancin lokuta masu rauni na mummunan tashin hankali, karuwa a cikin ayyukan transaminases da alkaline phosphatase, har ma da mutum, wataƙila mai mahimmanci, shari'o'in haɓakar hepatitis an bayyana su (wata alama ta haifar da haɗarin abinci na Orlistat ko hanyoyin ci gaba na pathophysiological ba a kafa su ba).

Tare da yin amfani da Orlistat a lokaci guda tare da maganin rashin daidaituwa na mutum, lokuta na raguwar prothrombin, karuwa a cikin dabi'un MHO da rikicewar anticoagulant mara daidaituwa, wanda ya haifar da canji a cikin sigogi hemostatic.

An ba da rahoton cututtukan jini na huda, diverticulitis, pancreatitis, cholelithiasis, da oxalate nephropathy (yawan lokuta ba a sani ba).

Tare da gudanar da kai-tsaye na Orlistat da magungunan antiepilepti, an lura da yanayin ci gaban abubuwa (duba. "Haɗawa").

Haɗa kai

Babu wata ma'amala ta Orlistat tare da amitriptyline, atorvastatin, biguanides, digoxin, fibrates, fluoxetine, losartan, phenytoin, maganin hana haihuwa, abubuwan mamaki, pravastatin, warfarin, nifedipine GITS (maganin jijiyoyin ciki tare da ko dangane da nazarin cudanya tsakanin kwayoyi). Koyaya, ya zama dole don saka idanu akan aikin MHO tare da jiyya ta lokaci daya tare da warfarin ko wasu maganin rashin daidaituwa.

Tare da gudanarwa na lokaci ɗaya tare da orlistat, an lura da raguwa a cikin ƙwayar bitamin D, E da beta-carotene. Idan ana bada shawarar multivitamins, ya kamata a ɗauka aƙalla 2 hours bayan shan orlistat ko kafin lokacin kwanta barci.

Tare da gudanarwa na lokaci-lokaci na Orlistat da cyclosporine, an lura da rage yawan cyclosporine a cikin jini na jini, saboda haka, an yanke shawarar mafi yawan akai-akai na maida hankali akan ƙwayar cuta a cikin jini yayin da ake shawarar cyclosporine da orlistat.

Lokacin da aka shigo da amiodarone a lokacin jiyya na orlistat, an lura da raguwar yanayin shigar amiodarone da desethylamiodarone (da kashi 25-30%), duk da haka, saboda hadaddun magunguna na amiodarone, mahimmancin asibiti wannan sabon abu ba a fili yake ba. Orara orlistat zuwa maganin jiyya na dogon lokaci tare da amiodarone na iya haifar da raguwa a cikin tasirin warkewar amiodarone (ba a gudanar da binciken ba).

Ya kamata a guji kula da tsarin orlistat da acarbose saboda ƙarancin karatun likitancin.

Tare da kulawa na lokaci-lokaci na Orlistat da magungunan antiepilepti, an lura da maganganun ci gaban mawuyacin hali. Ba a kafa dangantakar alaƙa tsakanin haɓakar jijiyoyi da cututtukan daji na orlistat ba. Koyaya, ya kamata a kula da marasa lafiya don canje-canjen da zasu yiwu a cikin tasirin da / ko tsananin tsananin ciwo.

Sashi da gudanarwa

A ciki wanke da ruwa.

Jiyya na marasa lafiya masu kiba tare da BMI na aƙalla 30 kg / m 2 ko kuma masu kiba masu yawa tare da BMI na akalla 28 kg / m 2, incl. yana da abubuwan haɗari da ke haɗuwa da kiba, a haɗe tare da rage yawan abinci mai gina jiki na hypocaloric: manya da yara sama da shekara 12 - shawarar da aka bada shawarar Listat shine kwamfutar hannu 1. (120 MG) tare da kowane babban abinci (tare da abinci ko kuma ba a wuce sa'a 1 ba bayan cin abinci).

A hade tare da magungunan hypoglycemic (metformin, abubuwan da ake samowa na sulfonylurea da / ko insulin) da / ko rage yawan hypocaloric na abinci a cikin marasa lafiya da ke fama da nau'in ciwon sukari na 2 na masu ƙiba ko masu kiba: manya - shawarar da aka bada shawarar Listat shine kwamfutar hannu 1. (120 MG) tare da kowane babban abinci (tare da abinci ko kuma ba a wuce sa'a 1 ba bayan cin abinci).

Idan abincin ya tsallake ko abincin bai ƙunshi mai ba, to cinye na Listat shima za'a iya tsallake shi.

Listat yakamata a ɗauka a hade tare da daidaita daidaitaccen abinci mai ɗauke da jini wanda ya ƙunshi adadin kuzari fiye da 30% a cikin fats. Abincin yau da kullun na kitse, carbohydrates da sunadarai dole ne a rarraba tsakanin manyan abinci 3.

Haɓaka cikin kashi na Listat akan maganin da aka bada shawarar (120 mg sau 3 a rana) baya ƙaruwa da warkewarta.

Groupsungiyoyin haƙuri na musamman

Ba a bincika tasiri da amincin Listat a cikin marasa lafiya da ke fama da cutar hanta da / ko aikin koda, da a cikin tsofaffi marasa lafiya da yara waɗanda shekarunsu ba su 12 ba.

Yawan abin sama da ya kamata

A cikin mutane masu nauyin jiki na yau da kullun da masu fama da kiba, gudanarwar allurai guda ɗaya na 800 MG ko yawancin allurai na orlistat 400 MG sau 3 a rana don kwanaki 15 ba tare da bayyanar manyan halayen haɗari ba. Bugu da ƙari, marasa lafiya tare da kiba suna da gogewa ta amfani da 240 MG na orlistat sau 3 a rana don watanni 6, wanda ba a haɗu da babban ƙaruwa a cikin yawan lokuta masu illa.

A cikin yanayin yawan zubar da jini na Orlistat, ko dai kasancewar abubuwan da suka faru da mummunan sakamako, ko kuma abubuwan da suka faru marasa illa ba su bambanta da waɗanda aka lura ba lokacin shan allurai na maganin warkewa.

Idan aka samu matsalar yawan tonon abinci na Orlistat, ana bada shawara a lura da mara lafiya na awanni 24. Dangane da karatuttukan cikin mutane da dabbobi, duk wani tasirin tsarin da zai iya danganta shi da maganin lipase-inhibiting Properties na orlistat ya kamata a sake canzawa da sauri.

Yanayin ajiya

Ana ba da magani ne kawai ta hanyar takardar sayan magani.

p, blockquote 50,0,0,0,0 ->

Kiyaye miyagun ƙwayoyi daga isa ga yara. Yawan zafin jiki na wurin ajiya kada ya wuce digiri 25, zafi - ba fiye da 70% ba.

p, blockquote 51,0,0,0,0 ->

Duba marufin don ranar karewa. Bai wuce shekara 2 ba daga ranar da aka ƙera shi.

p, blockquote 52,0,0,0,0 ->

p, blockquote 53,0,0,0,0 ->

Kasuwancin kantin magani yana ba da babban zaɓi na kwayoyi masu kyau, babban kayan abinci shine Orlistat. Ana amfani da samfuran analog ɗin masu zuwa iri ɗaya, amma alamun kasuwanci ɗaiɗaice ne ga kowane mabukaci.

p, blockquote 54,0,0,0,0 ->

Muna bayar da adadin magunguna iri daya masu kama da matsakaicin farashin:

p, blockquote 55,0,0,0,0 ->

• Allunan Allunan 120 MG, 30 inji mai kwakwalwa. (Izvarino-Pharma, Russia) - 874 rubles.,
• Xenalten capsules 120 MG, 21 inji mai kwakwalwa. (Obolenskoye FP, Russia) - 715 rubles.,
• Xenical capsules 120mg 21 inji mai kwakwalwa. (F. Hoffmann - La Roche Ltd (Switzerland)) - 941 rubles.,
• Orsoten capsules 120 MG, 21 inji mai kwakwalwa. (Krka, Slovenia) - 816 rubles.,,
• Orlistat capsules 120 MG, 20 inji mai kwakwalwa. (IBN Hyan Magunguna, Siriya) - 912 rubles.

Ya kamata a tuna cewa magani na kai ba tare da likita na zamani ba na iya lalata lafiyar ku. Wannan ba kawai zai kawo sakamakon da ake so ba, amma zai tsananta yanayin duka.

Yaya Listata aiki kuma menene ya ƙunshi?

Maganin yana maganin hana hancin ciki. A karkashin aikin da miyagun ƙwayoyi, an samar da mahadi na musamman a cikin jikin mutum, saboda wanda ke iya lalata fats da carbohydrates. Babban fasalin kayan aikin shi ne cewa lokacin da ake amfani da shi, kayan aikin da ke aiki ba su cika jikin su ta ganuwar hanjin ciki ba.

Godiya ga wannan, allunan a zahiri basu haifar da mummunan sakamako ba (kawai idan ba'a lura da lokacin sarrafawa da sashi ba) kuma baya zama jaraba. A ƙarshen banbanci na ƙimar kuzarin ƙimar samfuran da aka ƙone, ana lura da raguwa a cikin nauyin jikin mutum.

Listata ba ƙari ba ne ta hanyar ilimin halitta, saboda mahimman ɓangarorinta, ana kiran maganin a matsayin magani. An nuna wannan maganin don amfani da marasa lafiya waɗanda ke bincikar lafiya tare da kiba.

Babban abu mai aiki na miyagun ƙwayoyi shine orlistat, yana taimakawa rage jinkirin haɗarin abubuwa na enzymatic da ke tattare da rushewar kitse a jiki. Saboda wannan kayan, ciki kawai ba ya aiwatar da adadin kuzari mai yawa daga abinci (kusan 30%), ana jigilar su a cikin asalin asali zuwa tsarin hanji, sannan kuma cire shi daga ciki yayin lalata.

Abu na biyu mai mahimmanci a cikin abun da ke ciki na samfurin don asarar nauyi shine gum arabic (acacia gum). Wannan abun yana hana samuwar kitse mai yawa ta hanyar cire su daga jiki a kananan adadi. Saboda wannan, halayen da ba su dace ba, idan sun faru, ana yin rauni sosai. Wannan fa'idodi ne na Leafa idan aka kwatanta da sauran, mai kama da sifa da kaddarorin, kwayoyi don asarar nauyi.

A cikin hanyar ƙarin kayan haɗin, an yi amfani da microcellulose, magnesium stearate da sodium lauryl sulfate.

Umarnin don amfani

Wajibi ne a sha miyagun ƙwayoyi bin tsarin da sashi: 120 MG (1 kwamfutar hannu 1) sau uku a rana (tare da babban abincin, ko sa'a daya bayan cin abinci, amma ba daga baya ba). An hana shi ƙara yawan ƙwayar, saboda wannan na iya tayar da haɓakar halayen mara kyau, kuma ba inganta sakamakon amfani da miyagun ƙwayoyi ba.

Bugu da kari, idan abincin ya ƙunshi adadin kuzari da kitsen (alal misali, menu ya ƙunshi salatin kayan lambu da nono mai dafaffun nama), ana bada shawarar tsallake shan maganin.

Mahimmanci! Doka ya zaɓi tsawon lokacin da ake yin jiyya don asarar nauyi, a kowane yanayi, yana iya kasancewa daga watanni shida zuwa shekaru 4.

Ya kamata a lura cewa mutumin da yake ƙoƙarin rasa nauyi yana buƙatar sake duba abincin nasa. Wato, don sanya rabo ya ɗan ɗan ƙarami, kuma ya haɗa a cikin samfuran menu wanda ake ɗauke da kitse a cikin adadi kaɗan. Lokacin da likita ya ba da izini ga Listat, yana ba da shawara ban da shan magunguna don bi da ƙarancin kalori - ya kamata ku ci bambance bambancen, amma darajar kuzarin yau da kullun abincin da kuke ci bai wuce adadin kuzari 1300-1500 ba. A ƙarƙashin yanayin yin wasanni, ana iya ƙara kashi zuwa adadin kuzari 1600-1900.

Side effects da yawan abin sama da ya kamata

Idan kun sha kwayoyin, kuma kuna keta alfarmar da aka tsara, to akwai yuwuwar illolin da suka samu.

Sakamakon sakamako na miyagun ƙwayoyi

Dangane da yanayin ciki da hanji lokacin amfani da magani, rashin jin daɗin ciki, yawan motsa jiki don lalacewa, rashin jin daɗi, da rashin daidaituwa na iya yiwuwa. Tunda kitsen bai cika narkewa a jiki ba, feces ne mai, wanda yakan sa rigunan jikinki yayi rauni.

Game da tsarin hematopoietic, samuwar anemia yana yiwuwa. Wannan ilimin haɓaka yana haɓaka tare da isasshen adadin haemoglobin a cikin jini wanda aka samar da ƙwayoyin ja. Don saka idanu da wannan alamar, ana bada shawara don yin gwajin jini a asibiti kafin ɗaukar maganin kuma a ƙarshen hanya. Don kula da haemoglobin tsakanin daidaitaccen al'ada, yakamata a hada da abubuwan da suke da ƙarfe a cikin abincin.

Tsarin juyayi na tsakiya yana amsawa ga kulawa mara kyau ta Listata tare da bayyanar da damuwa mai sauƙi saboda matattara mai rauni, kodayake wannan yanayin al'ada ne kuma ba'a la'akari da cuta ba.

Don hana haɓakar halayen cuta marasa kyau, kuna buƙatar tuntuɓi likita kafin amfani da ganyen kuma a ƙarshen hanya. Hakanan wajibi ne don yin gwaji don sanin canje-canjen da suka faru a jikin mutum.

Idan aka ƙayyade adadin magungunan da aka ƙayyade ya wuce, kuma na dogon lokaci, irin waɗannan ayyuka suna haɓaka a cikin lokuta masu wuya. Amma a cikin irin wannan yanayin, ana ba da shawarar kula da lafiyar mai haƙuri a cikin kullun. A matsayinka na mai mulkin, duk wani sakamako na tsari wanda ya danganta da rage karfin lipase a karkashin tasirin babban aikin mai aiki da sauri zai wuce.

A cikin kantin magunguna, zaku iya samun wasu magunguna tare da irin tasirin, sashin da ke aiki wanda shine orlistat. Wadannan sun hada da:

Bugu da ƙari, akwai magunguna tare da wani abu mai aiki wanda shima yana taimakawa rage nauyi: Liraglutid, Reduxin. Amma kowane ɗayan waɗannan magungunan ana bada shawarar don amfani kawai bayan shawarar likita.

Listata ko Orlistat: wanda yafi kyau

Idan ka kwatanta wane samfurin ne mafi kyau - Orlistat ko Listata, ya kamata a lura cewa babban fa'idar ƙarshen shine mafi karɓar kuɗin shiga. Bugu da kari, Listata ta sami damar kara tsoratar da ci gaban halayen rashin daidaituwa idan aka kwatanta ta da Orlistat. A cikin sharuddan gaba ɗaya, ka'idar aiwatar da kwayoyi iri ɗaya ce.

Farashi da sharuɗan hutu a kantin magani

Za'a iya siye Listata ta hanyar samar da takardar sayan magani daga likita kawai. Kudaden magungunan cikin gida kimanin. 400 rubles, kuma farashin kudaden da aka samar a Switzerland zai kasance kusan 1000 rubles.

A takaice game da miyagun ƙwayoyi

Ra'ayoyi game da "Jerin" suna jaddada cewa wannan maganin sahihanci ne ga mutane da yawa. Wani kari ne na kayan halitta wanda zai baka damar rasa nauyi cikin sauri.

Wannan kayan aiki kawai yana tsoma baki tare da ɗaukar mai. Ba shi da tasirin mu'ujiza a jikin ɗan adam. Reviews on "Jerin" ya nuna cewa likitanci galibi yana ba da shawarar wannan maganin. Dangane da haka, ba lallai ba ne a dauke shi a matsayin zamba na kudi.

Fom ɗin saki

Yaya magungunan da aka yi binciken suka yi kama? Yanayin sakin sa baya farantawa kowa rai.

Abinda yake shine sake dubawa game da "Listat" yana haifar da ƙari ga nazarin halittu saboda ba mai sauƙin amfani bane. Hanyar maganin yana cikin allunan, an rufe shi tare da harsashi mai santsi. Sun yi kama da kawa.

Akwai kunshin magunguna masu girma dabam. Misali, tsara don 60 ko 90 capsules. Na dabam, blister "Allunan" ba na siyarwa bane.

Yaushe yakamata ku kula da maganin da akayi nazari? Bayan haka, sake nazarin "Listat Mini" sun bambanta wannan samfurin ba azaman ƙarin nazarin halittu mai sauƙi ba. Mutane sun ce ya fi kyau a yi amfani da irin waɗannan kwayoyin a takamaiman yanayi.

Iyakar abin da kawai ke nuna alama ga Listata shine kiba. Ana amfani da kwayoyin hana daukar ciki don mutum ya rasa nauyi mai yawa. Su, a cewar masu samarwa, suna da mummunar tasiri. Ba tare da kiba ba, zai fi kyau kar a ɗauki Listat.

Ba duk mutane bane ke iya shan magani tare da maganin da aka yi nazari akai. Ga "Listata" da ba a ba shi izini?

Wadannan mutane sun hada da wadanda ke fama da wadannan cututtukan:

• rashin lafiyan halayen,
• mutum mai haƙuri da magani,
• cholestasis
• lokacin shan maganin hana daukar ciki,
• matsalolin gastrointestinal,
• cutar koda
• shekarun yara.

Shin zai yiwu a yi amfani da ƙarin nazarin nazarin halittu yayin ciki ko lokacin shaƙatawa. Binciken da aka yi akan Miniat Mini ya nuna cewa lokutan da aka lissafa kuma sun hana amfani da kudade. Yana da kyau a cire ta ko da a matakin tsarin daukar ciki ne.

Tasiri

Menene Listata? Umarnin don amfani, farashi, ra'ayoyi da ra'ayoyin likitoci game da irin wannan ƙarin ilimin halittu an gabatar dasu ga hankalin mu. Ana taka rawar gani sosai sakamakon tasirin aikin jiyya. Bayan duk, mutane suna rayayye suna sayan tsada, amma ingantacciyar hanya don magance cututtuka daban-daban.

A cikin wannan yanki, an rarraba bita zuwa kashi biyu - ra'ayoyi masu kyau da mara kyau. Dayawa suna cewa “Listata” bai taimaka wajen rage nauyi ba. Ko kuma ta yi ayyukanta ne sosai.

Ra'ayoyi suna rasa nauyi akan "Jerin" suna cewa kayan aiki yana taimakawa sosai. Amma don iyakar sakamako, dole ne ku kusanci batun batun rashi nauyi a bayyane. Wato, yana da mahimmanci a ci abinci da motsa jiki yadda yakamata. Sannan zai yuwu a rasa kilogram 10 a kowane wata. Wannan yana da yawa.

Likitoci game da maganin

Mutane da yawa suna shirye su biya kowane kuɗi don ingantattun magunguna don asarar nauyi. Me likitoci ke faɗi game da Listat?

Kusan dukkanin masana suna jaddada ingancin maganin. A cikin lura da kiba, wannan ƙwayar magunguna yawanci ana wajabta shi. Abubuwan da ke aiki a cikin kayan "Leaf" suna ba da gudummawa ga ƙarancin shan mai. Saboda wannan, abubuwa masu wuce haddi ake cirewa daga jiki. Add da nazarin halittu ba ya ɗaukar wata babbar illa.

Yana da mahimmanci a lura cewa masana sunyi magana game da ingantaccen aikin asibiti na abincin abinci. Don haka, a cikin yaki da kiba, Listat zai shigo da hannu.

Game da fasali

Yana da mahimmanci a fahimci cewa amfani da magani guda ɗaya na asarar nauyi bai isa ba. Abinda yake shine "Listata" yana baka damar iyakance kawai kashi 30% na fatun masu shigowa. Don iya aiki mafi girma dole ne:

• hana abinci mai kitse,
• jagoranci rayuwa mai aiki
• Bi duk shawarar da masana ilimin abinci suka bayar,
• guji damuwa.

A wannan yanayin ne kawai zamu iya fatan kyakkyawan sakamako daga jiyya tare da magani na Listata.

Kamar kowane magani, allunan da muka yi nazarin suna da analogues. Neman magani mai mahimmanci don asarar nauyi kusan ba zai yiwu ba.

Yaya za a maye gurbin "Jerin"? Munyi nazarin koyarwar, bita da farashin kayan abinci. Daga cikin analogues na kudaden da aka ambata sune mafi yawan lokuta ana rarrabe su:

• "Orlimaks" (Maganin Poland don asarar nauyi).
• "Orsoten".
• "Allie."
• Xenalten.

A duk waɗannan abubuwan abinci, kayan aiki iri ɗaya ne orlistat. Wanne ya fi kyau a zabi? An bada shawara don fayyace wannan batun tare da likitan ku.

Haihuwa da lactation

A cikin nazarin cututtukan cututtukan dabbobi a cikin dabbobi, ba a lura da tasirin teratogenic da tayi ba. Idan babu tasirin teratogenic a cikin dabbobi, ba a tsammanin irin wannan sakamako a cikin mutane. Tunda babu bayanan asibiti game da amfani da miyagun ƙwayoyi a lokacin daukar ciki, amfani da miyagun ƙwayoyi a cikin mata masu juna biyu yana haɓaka.

Sakamakon cewa babu bayanai game da rarraba magunguna tare da madara, an hana contraindicated amfani da miyagun ƙwayoyi.